Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ismat Khatri

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Transplantation|October 24, 2008
Identification of an expressed truncated form of CD200, CD200tr, which is a physiologic antagonist of CD200-induced suppressionZhiqi Chen, Dang-Xiao Chen, Yu Kai, et al.
Blood Advances|March 28, 2024
Double-negative T cells utilize a TNFα-JAK1-ICAM-1 cytotoxic axis against acute myeloid leukemiaEnoch Tin, Jong Bok Lee, Ismat Khatri, et al.
Breast Cancer Research and Treatment|December 3, 2009
Breast cancer cell CD200 expression regulates immune response to EMT6 tumor cells in miceReginald M Gorczynski, Zhiqi Chen, Jun Diao, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 14, 2009
Expression of a CD200 transgene is necessary for induction but not maintenance of tolerance to cardiac and skin allograftsReginald M Gorczynski, Zhiqi Chen, William He, et al.
Transplantation|June 16, 2010
Potent immunosuppression by a bivalent molecule binding to CD200R and TGF-betaRReginald M Gorczynski, Zhiqi Chen, Saaiis Shivagnahnam, et al.
Plos One|April 26, 2016
Characterization of CD200 Ectodomain SheddingKarrie K Wong, Fang Zhu, Ismat Khatri, et al.
Molecular Therapy. Nucleic Acids|August 27, 2014
Agonistic CD200R1 DNA Aptamers Are Potent Immunosuppressants That Prolong Allogeneic Skin Graft SurvivalAaron Prodeus, Marzena Cydzik, Aws Abdul-Wahid, et al.
Science Immunology|April 22, 2022
Allogeneic double-negative CAR-T cells inhibit tumor growth without off-tumor toxicitiesDaniel Vasic, Jong Bok Lee, Yuki Leung, et al.
Cancers|October 23, 2021
Enhancing Therapeutic Efficacy of Double Negative T Cells against Acute Myeloid Leukemia Using IdelalisibHyeonjeong Kang, Jong Bok Lee, Ismat Khatri, et al.
Journal for Immunotherapy of Cancer|April 17, 2025
Single-cell RNA sequencing of human double-negative T cells reveals a favorable cellular signature for cancer therapyEnoch Tin, Ismat Khatri, Karen Fang, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Transplantation|October 24, 2008
Identification of an expressed truncated form of CD200, CD200tr, which is a physiologic antagonist of CD200-induced suppressionZhiqi Chen, Dang-Xiao Chen, Yu Kai, et al.
Blood Advances|March 28, 2024
Double-negative T cells utilize a TNFα-JAK1-ICAM-1 cytotoxic axis against acute myeloid leukemiaEnoch Tin, Jong Bok Lee, Ismat Khatri, et al.
Breast Cancer Research and Treatment|December 3, 2009
Breast cancer cell CD200 expression regulates immune response to EMT6 tumor cells in miceReginald M Gorczynski, Zhiqi Chen, Jun Diao, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 14, 2009
Expression of a CD200 transgene is necessary for induction but not maintenance of tolerance to cardiac and skin allograftsReginald M Gorczynski, Zhiqi Chen, William He, et al.
Transplantation|June 16, 2010
Potent immunosuppression by a bivalent molecule binding to CD200R and TGF-betaRReginald M Gorczynski, Zhiqi Chen, Saaiis Shivagnahnam, et al.
Plos One|April 26, 2016
Characterization of CD200 Ectodomain SheddingKarrie K Wong, Fang Zhu, Ismat Khatri, et al.
Molecular Therapy. Nucleic Acids|August 27, 2014
Agonistic CD200R1 DNA Aptamers Are Potent Immunosuppressants That Prolong Allogeneic Skin Graft SurvivalAaron Prodeus, Marzena Cydzik, Aws Abdul-Wahid, et al.
Science Immunology|April 22, 2022
Allogeneic double-negative CAR-T cells inhibit tumor growth without off-tumor toxicitiesDaniel Vasic, Jong Bok Lee, Yuki Leung, et al.
Cancers|October 23, 2021
Enhancing Therapeutic Efficacy of Double Negative T Cells against Acute Myeloid Leukemia Using IdelalisibHyeonjeong Kang, Jong Bok Lee, Ismat Khatri, et al.
Journal for Immunotherapy of Cancer|April 17, 2025
Single-cell RNA sequencing of human double-negative T cells reveals a favorable cellular signature for cancer therapyEnoch Tin, Ismat Khatri, Karen Fang, et al.
Pageof 4